Cyclophosphamide and malignancy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy; D007938:Leukemia / Q000139:chemically induced; D008223:Lymphoma / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced* / Q000188:drug therapy; D013997:Time Factors
D003520:Cyclophosphamide